IRCT20140715018490N4招募中3 期
To evaluate the efficacy and side effects of using the Ma-al-Jobn in treatment of diabetic type II patients as a complementary therapy
Fasa University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 65 years（—）
- 性别
- All
入选标准
- •Presence of diabetes (FBS>126 mg/dl)
- •Have a FBS less than 250 and HgbA1c more than 6.4
- •Age between 30 to 65 years
- •No systemic diseases like; liver, renal, rheumatologic diseases or hypertension
- •No consume any anti-diabetic or corticosteroid drugs 2 weeks before the study
- •No drink alcohol or use opium
- •Weight less than 100 kg
- •Have a BMI less than 35
排除标准
- •No agree to participate in the study
- •Have a FBS more than 270 mg/dl
- •Consuming corticosteroid drugs during the study
- •Presence of any side effects
研究者
相似试验
招募中
3 期
To evaluate Fenugreek and Bitter apple in treatment of diabetesDiabetes.Type 2 diabetes mellitusIRCT20140715018490N3Fasa University of Medical Sciences74
已完成
不适用
The evaluation of subsicion in the correction of nasolabial fold depthasolabial fold.Other atrophic disorders of skinIRCT201705278146N19Vice chancellor for research,Shahid Beheshti University of Medical Sciences10
招募中
Unknown
effectiveness and side effects of Spinaraza and Risidiplam on the motor performance of patients with spinal muscular atrophyIRCT20120821010634N4Hamedan University of Medical Sciences30
招募中
3 期
The effect of deep lung support capsule in idiopathic pulmonary fibrosisIdiopathic Pulmonary Fibrosis.J84.112Idiopathic pulmonary fibrosisIRCT20230509058135N1Shahid Beheshti University of Medical Sciences70
进行中（未招募）
1 期
Study to evaluate the efficacy and side effects of Envarsus in patients who had a kidney transplantatioKidney transplant immunosupression for patients with CYP3A5*1 gene varianceMedDRA version: 20.0Level: PTClassification code 10023439Term: Kidney transplant rejectionSystem Organ Class: 10021428 - Immune system disordersEUCTR2020-001101-22-NLAmsterdam UMC25